Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-552-5 | CAS number: 122-52-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
A reproduction/developmental toxicity screening test was performed (OECD TG 421, GLP) in Wistar rats, which were dosed with 10, 80, 320, and 640 mg/kg bw two weeks before mating, during the 2 week mating and 1-week remating period, during gestation, lactation and up to the day before necropsy (males were necropsied on day 36 to 37 of treatment, females between day 4 to 6 post partum; Bayer AG, 2002). In the parent animals mortality, observation, body weight, food consumption, water consumption, time to insemination, insemination index, fertility index, duration of gestation, gestation index, number of corpora lutea, number of implantations were examined. Pathological and histopathological observations of testes, epididymides, ovaries, mammae, uterus, vagina and organs with macroscopically altered tissues were performed.
General toxicity: Animals of both sexes in the high dose group (640 mg/kg bw/day) exhibited clear clinical signs of systemic toxicity (e.g. piloerection, sunken sides, tremors, salivation immediately after dosing, recumbency) and body weight loss (> 14% decrease relative to controls in males and females). All females of this group were killed in moribund condition. Similar signs of toxicity were seen in individual females of the 320 mg/kg bw/day group. Slight weight loss was recorded in individual females after exposure to 80 mg/kg bw/day before the increase of weight due to gestation. Salivation was observed in males of all dose groups with a dose-related increase and in females of the 80, 320 and 640 mg/kg bw/day groups.
Effects on Fertility: Histopathology showed minimal to slight degeneration in the germinal epithelium of testes, and apoptosis and/or regenerative hyperplasia in the testes and epididymides, after exposure to the clearly paternally toxic dose level of 640 mg/kg bw/day. Relative testes weights (%) were 0.87, 0.89, 0.91, 0.85, and 0.98 (statistically significant) for controls, 10, 80, 320 and 640 mg/kg bw/day groups, respectively. There was no significant difference in absolute testes weights between the groups. In females, histopathology revealed slight proliferation / secretion in the mammary gland together with mucification in the cervix and vagina in all females at 640 mg/kg bw/day, which were sacrificed in moribund state either after 8 to 10 days of pairing or during early gestation. No histopathological changes were recorded in reproductive organs up to and including a dose of 320 mg/kg bw/day. Only 5 of 12 females were inseminated in the 640 mg/kg bw/day group. Evaluation of other data regarding reproductive performance, including early postnatal development of pups for the 640 mg/kg bw/day group was not possible. At a dose level of 320 mg/kg bw/day an increase in time to insemination, slightly decreased duration of gestation, a severely reduced gestation rate, distinctly increased number of stillborn/dead F1 pups, and a distinctly decreased number of viable/total number of pups were recorded. Pups showed severely reduced birth weights, hypothermia and severely reduced survival. No effects on the other reproductive parameters (insemination index, fertility index, numbers of corpora lutea and implantation sites, prenatal loss, litter size) were detected up to and including a dose level of 320 mg/kg bw/day.
Conclusion: In a screening study in rats according to OECD TG 421, effects on fertility were seen in females at 320 mg/kg bw/day in the presence of general toxicity as an increase in time to insemination, severely reduced gestation rate, and an increase in stillbirths and dead pups. Male rats showed changes in the testes at the severely toxic dose of 640 mg/kg bw/day. (NOAEL females: 80 mg/kg bw/day; NOAEL males: 320 mg/kg bw/day).
Short description of key information:
In a screening study in rats according to OECD TG 421, effects on fertility were seen in females at 320 mg/kg bw/day in the presence of general toxicity as an increase in time to insemination, severely reduced gestation rate, and an increase in stillbirths and dead pups. Male rats showed changes in the testes at the severely toxic dose of 640 mg/kg bw/day. (NOAEL females: 80 mg/kg bw/day; NOAEL males: 320 mg/kg bw/day).
Effects on developmental toxicity
Description of key information
In a screening study in rats according to OECD TG 421, developmental toxicity was found at dose levels ≥ 320 mg/kg bw/day as evidenced by severely reduced survival and reduced pup birth weights (NOAEL: 80 mg/kg bw/day).
Additional information
A reproduction/developmental toxicity screening test was performed (OECD TG 421, GLP) in Wistar rats, which were dosed with 10, 80, 320, and 640 mg/kg bw two weeks before mating, during the 2 week mating and 1 -week remating period, during gestation, lactation and up to the day before necropsy (males were necropsied on day 36 to 37 of treatment, females between day 4 to 6 post partum; Bayer AG, 2002). In the pups appearance (including externally visible malformations), general behaviour, mortality, sex ratio at birth, individual weights at birth and on day 4 after birth were examined (Bayer AG, 2002).
In F1, the sex ratio, mortality and weights were not affected by treatment up to and including doses of 80 mg/kg bw/day, while evaluation was not possible at higher doses as there were no surviving pups. No externally malformed pups were observed.
Conclusion:
In a screening study in rats according to OECD TG 421, developmental toxicity was found at dose levels ≥ 320 mg/kg bw/day as evidenced by severely reduced survival and reduced pup birth weights (NOAEL: 80 mg/kg bw/day).
Justification for classification or non-classification
The available data are insufficient for assessment of the reproductive toxicity of the test substance.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.